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In yeast, revertants were selected from two respiratory deficient mutants carrying mutations in the catalytic subunits of cytochrome oxidase. From 
a mutant carrying a double mutation in the vicinity of the copper binding pocket in subunit II, two genetically independent revertants were obtained 
in which the same extragenic reversion mutation was observed, A147V, in the putative helix 4 of subunit I. A comparison with revertants derived 
from the second deficient mutant, carrying the deficiency mutation, S14OL, in the loop 334 of subunit I, provides additional data in favour of an 
interaction between helix 4 of subunit I and subunit II. 
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1. INTRODUCTION 
Mitochondrial cytochrome c oxidase is the major ter- 
minal oxidase in eukaryotes. It is a member of a large 
family of protomnotive oxidases [l]. The mitochondrial 
enzyme has up to 13 subunits [2] but only the three 
mitochondrially-encoded subunits (I, II and III) form 
the essential catalytic unit which is common to all super- 
family members. 
Most, if not all, of the prokaryotic enzymes in this 
superfamily have subunits which are homologues of the 
three mitochondrially encoded subunits (I, II and III) 
of the eukaryotic oxidase. The bacterial systems have 
allowed the application of site-directed mutagenesis and 
this has provided a major contribution to the significant 
advances in understanding of their structure which have 
been made recently [3-51. 
In the eukaryotic system, in contrast to the bacterial 
system, subunits I, II and III which are directly involved 
in the catalytic activity are encoded by the mitochon- 
drial DNA and thus are not easily manipulated by site- 
directed mutagenesis. Nevertheless, the eukaryotic sys- 
tems (and yeast in particular) have complementary in- 
formation to offer. The characterisation of random mu- 
tants and their revertants may allow otherwise unsus- 
pected important regions of the protein to be identified, 
and provides a means of determining parts of the pro- 
tein which may be close to each other [6-g]. 
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This approach also provides a means of obtaining 
information on the interactions between subunits I, II 
and III. Starting from a deficient mutant L3, carrying 
a double mutation in the COX 2 gene, spontaneous 
revertants were selected. In addition to the intragenic 
revertants, two genetically independent but identical ex- 
tragenic revertants have been obtained. The extragenic 
mutation responsible for the restoration of the respira- 
tory growth ability was located in the COX 1 gene. 
2. MATERIALS AND METHODS 
The strains, media and selection of the revertants were described in 
[9]. The ethidium bromide mutagenesis was described in [lo]. 
3. RESULTS AND DISCUSSION 
3.1. Revertants derivedfrom the subunit II deficient mu- 
tant 
The deficiency mutation L3 has been mapped in the 
COX 2 gene. The mutation leads to an inability to grow 
on glycerol medium even although the mutant contains 
optically-detectable oxidase [6,7]. 
The sequencing of the COX 2 gene of the mutant has 
been performed as described in [6]. Two mutations were 
observed, A189V and V22OV. The double mutation is 
located in the vicinity of the predicted copper binding 
pocket of the subunit II [I l-131. 
Revertants have been selected. The mitochondrial he- 
redity of the reversion was determined before sequenc- 
ing as described in [9,10]. Mutations have been se- 
quenced directly on DNA segments amplified by 
polymerase chain reaction [6]. The results are presented 
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Fig. 1. Localisation of the amino acid replacements in the folding model of the cytochrome oxidase subunits I and II. Only helices 1 to 5 of the 
subunit I are represented. H is histidine 62, one of the two ligands of haem a. In the subunit II model, adapted from [ll], the ligands of Cu, are 
noted in bold letters, H186, C221, C225 and H229. The deficiency mutations in subunits I and II and the second-site reversions are in bold letters. 
The arrows point to the second-site reversions. 
in Table I. Wild type reversion was not found. However 
reversions at each mutated site were identified suggest- 
ing that each mutation alone is responsible for a defi- 
ciency phenotype and each reversion compensates the 
other deficiency mutation. In addition, a distant rever- 
sion was found in the COX 1 gene. The amino acid 
replacement, A147V, is located in the putative helix 4 
of the model (Fig. 1). This extragenic reversion was 
Table I 
Codon and amino acid replacements in the subunit II mutant, L3 and 
the revertants 
Strains Initial mutations Distant Number 
loci in subunit II reversion locus of 
in subunit revertants 
Wild type Al89 A220 Al47 
GCT GCA GCA 
L3 A189V A22OV 
GCT>GTT GCA>GTA 
Revertant V189F A220V 11 
GTT > TTT 
Revertant A189V V220M 11 
GTA > ATA 
Revertant 
Revertant 
A189V V220G 1 
GTA > GGA 
A189V A22ov A147V 2 
GCA > GTA 
The revertants are selected and sequenced as described in [9]. They are 
spontaneous and genetically independent. 
observed in two genetically independent revertants and 
the sequencing data were confirmed by the genetic local- 
isation of the reversion. As described in [lo], a rho- 
clone (large deletion mutant) able to suppress the sub- 
unit II deficiency mutation was produced by ethidium 
bromide treatment. The mitochondrial genes retained 
by this rho- clone were determined by crossing with 
COX 1,2 and 3 deficiency mutations (data not shown). 
We observed that this rho- genome had lost the COX 
2 and COX 3 genes but retained the COX 1 gene. The 
sequencing of the COX 1 gene retained by the rho- 
clone has been performed and only the A147V mutation 
was observed. Therefore, the A147V mutation is consid- 
ered as responsible for the restoration of the respiratory 
competence. This result suggests a functional and 
maybe topological interaction between the copper bind- 
ing pocket of subunit II and helix 4 of the subunit I (Fig. 
1). 
3.2. Revertants derived from the subunit I deficient mu- 
tant 
The study of revertants selected from another defi- 
cient mutant (L176) has provided additional evidence in 
favour of the interaction. The L176 deficiency mutation 
has been mapped in a subregion of the COX 1 gene. 
This region was sequenced and an amino acid replace- 
ment, S14OL, has been observed. This change is located 
in the putative loop between helices 3 and 4, seven 
amino acids before the reversion mutation A147V (Fig. 
1). Revertants have been selected and sequenced as de- 
scribed [9]. The results are shown in Table II. Wild type 
reversion and non wild type reversion at the same locus 
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Table II 





Initital mutation Distant reversion Number 









TTA > CTA 
4 
3 
Revertant Sl4OL V60T 3 
GTT > CTT 
The revertants are selected and sequenced as described in [9]. They are 
spontaneous and genetically independent. 
(L14OT) were observed. Three genetically independent 
revertants were found to carry a second-site reversion 
of V6OT, two amino acids before H62 which is likely to 
be a ligand of the haem a. This result suggests a func- 
tional interaction and maybe topological proximity be- 
tween the loop 3-4 and the helix 2 which carries one of 
the ligands of haem a. 
As shown in Fig. 1, if residues 60 (helix 2) and 140 
(loop 3-4) are close in the three-dimensional structure, 
then the mutation A147V is also likely to be in the 
vicinity of the H62. Since this suppresses the subunit II 
mutation (A 189V + A220V), the results overall indicate 
that there may be proximity of the CuA ligands of sub- 
unit II and the haem a ligands of subunit I. This seems 
logical if we consider that the electrons are transferred 
from Cu, of subunit II to the binuclear centre via the 
haem a [14]. 
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